UNIVERSITY OF COLORADO SOUTHWEST ONCOLOGY GROUP

描述(改编自申请者S摘要)：加州大学 科罗拉多州癌症中心正在请求继续支持他们的 参加西南肿瘤学会(SWOG)。世界银行的使命是 科罗拉多大学癌症中心自成立以来，一直是 通过基础实验室研究、转移 通过转译研究将科学发现带到临床，以及 临床试验的设计、执行和分析。他们参与了 SWOG一直是科罗拉多大学使命的组成部分 癌症中心。在密歇根大学进行的机构试点研究 科罗拉多州已经以预期的形式被带到集团 随机试验。来自科罗拉多大学的SWOG成员和 继续为行政、教育和科学事业作出贡献 SWOG的功能。科罗拉多大学SWOG成员是主席或 下列委员会的联合主席：生殖泌尿外科(E.David博士 克劳福德)，血液和骨髓移植(伊丽莎白·施波尔博士)，GU 病理学(加里·米勒博士)和肺生物学(威尔伯·富兰克林)。斯科特博士 贝尔曼是SWOG的首席调查员，也是 州长们。除了这些行政贡献外，加州大学 科罗拉多州癌症中心成员是17名 在前一个授权期内激活的SWOG协议的百分比。 目前，科罗拉多大学的成员是 血液和骨髓移植，乳房，肺和骨科委员会。在.期间 未来五年，他们预计将继续做出重要的科学和 对这些委员会的行政捐助。此外，他们预计 在其他领域也作出贡献，包括放射治疗(雷切尔博士 Rabinovitch和Michael Weil)，发展治疗学(安德鲁博士 神经肿瘤学(伯特兰·梁博士)和癌症控制(玛丽博士 木材)。他们为我们对西南肿瘤学小组的贡献感到自豪 并致力于履行其使命。他们期待着自己的贡献 在接下来的5年里增加。

Description (Adapted from the applicant s abstract): The University of Colorado Cancer Center is requesting continuing support for their participation in the Southwest Oncology Group (SWOG). The mission of the University of Colorado Cancer Center has, since it's founding, been the reduction of cancer mortality through basic laboratory research, moving scientific discoveries to the clinic through translational research, and the design, execution, and analysis of clinical trials. Their participation in SWOG has been an integral part of the mission of the University of Colorado Cancer Center. Institutional pilot studies conducted at the University of Colorado have been brought to the Group in the form of prospective randomized trials. SWOG members from the University of Colorado have and continue to contribute to the administrative, educational and scientific functions of SWOG. University of Colorado SWOG members are chairs or co-chairs of the following committees: Genitourinary (Dr. E. David Crawford), Blood and Marrow Transplantation (Dr. Elizabeth Shpall), GU Pathology (Dr. Gary Miller), and Lung Biology (Wilbur Franklin). Dr. Scott Bearman is Principal Investigator for SWOG and sits on the Board of Governors. In addition to these administrative contributions, University of Colorado Cancer Center members are coordinators or co-coordinators of 17 percent of the SWOG protocols activated during the previous grant period. Presently, University of Colorado members are important contributors to the Blood and Marrow Transplantation, Breast, Lung, and GU Committees. During the next five years they expect to continue to make important scientific and administrative contributions to those committees. In addition, they expect to contribute in other areas as well, including radiotherapy (Drs. Rachel Rabinovitch and Michael Weil), developmental therapeutics (Dr. Andrew Kraft), neuro-oncology (Dr. Bertrand Liang) and Cancer Control (Dr. Marie Wood). They are proud of our contributions to the Southwest Oncology Group and are committed to its mission. They expect their contributions to increase during the next 5 years.